» Articles » PMID: 31910983

Diagnosis and Treatment of Eosinophilic Esophagitis

Overview
Date 2020 Jan 9
PMID 31910983
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Eosinophilic esophagitis (EoE) is an eosinophil-rich, T2 antigen-mediated disease of increasing pediatric and adult worldwide prevalence. Diagnosis requires greater than or equal to 15 eosinophils per high-power field on light microscopy. Symptoms reflect esophageal dysfunction, and typical endoscopic features include linear furrows, white plaques, and concentric rings. Progressive disease leads to pathologic tissue remodeling, with ensuing esophageal rigidity and loss of luminal diameter caused by strictures. Therapies include proton pump inhibitors, elimination diets, and topical corticosteroids. Effective treatment can reverse tissue fibrosis in some patients, as well as decrease the rate of food impactions. Esophageal dilation might be required to increase luminal patency. The chronic nature of EoE necessitates long-term therapy to avoid disease recurrence and complications. This review serves the function of providing the current state-of-the-art diagnostic criteria and disease management for adult and pediatric EoE.

Citing Articles

Differential diagnosis of eosinophilic oesophagitis variants and biomarker identification: current progress.

Hanczaruk B, Roszko A, Kaminski K, Tynecka M Cent Eur J Immunol. 2025; 49(4):438-441.

PMID: 39944254 PMC: 11811723. DOI: 10.5114/ceji.2024.143996.


The Dynamic Evolution of Eosinophilic Esophagitis.

Farah A, Assaf T, Hindy J, Abboud W, Mahamid M, Savarino E Diagnostics (Basel). 2025; 15(3).

PMID: 39941170 PMC: 11816659. DOI: 10.3390/diagnostics15030240.


An AI-assisted morphoproteomic approach is a supportive tool in esophagitis-related precision medicine.

Mattern S, Hollfoth V, Bag E, Ali A, Riemenschneider P, Jarboui M EMBO Mol Med. 2025; 17(3):441-468.

PMID: 39901020 PMC: 11903792. DOI: 10.1038/s44321-025-00194-7.


Epidemiology of Eosinophilic Esophagitis: Really a Novel and Evolving Disease?.

Mona R, Hruz P Inflamm Intest Dis. 2025; 10(1):34-40.

PMID: 39834520 PMC: 11745509. DOI: 10.1159/000543022.


Exploring the Impact of Gender on the Characteristics and Complications of Eosinophilic Esophagitis.

Patel H, Elmer J, Liaquat H JGH Open. 2024; 8(12):e70059.

PMID: 39713748 PMC: 11660561. DOI: 10.1002/jgh3.70059.


References
1.
Gonsalves N, Yang G, Doerfler B, Ritz S, Ditto A, Hirano I . Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology. 2012; 142(7):1451-9.e1. DOI: 10.1053/j.gastro.2012.03.001. View

2.
Philpott H, Nandurkar S, Royce S, Gibson P . Ultrathin unsedated transnasal gastroscopy in monitoring eosinophilic esophagitis. J Gastroenterol Hepatol. 2015; 31(3):590-4. DOI: 10.1111/jgh.13173. View

3.
Rodriguez-Sanchez J, Gomez Torrijos E, Lopez Viedma B, de la Santa Belda E, Martin Davila F, Garcia Rodriguez C . Efficacy of IgE-targeted vs empiric six-food elimination diets for adult eosinophilic oesophagitis. Allergy. 2014; 69(7):936-42. DOI: 10.1111/all.12420. View

4.
Aceves S . Food allergy testing in eosinophilic esophagitis: what the gastroenterologist needs to know. Clin Gastroenterol Hepatol. 2013; 12(8):1216-23. PMC: 4048803. DOI: 10.1016/j.cgh.2013.09.007. View

5.
Cohen M, Kaufman A, Palazzo J, Nevin D, Dimarino Jr A, Cohen S . An audit of endoscopic complications in adult eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2007; 5(10):1149-53. DOI: 10.1016/j.cgh.2007.05.017. View